Repro Med Systems
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $10,402 | $10,194 | $9,635 | $8,838 |
Gross Profit | 6,264 | 6,475 | 6,046 | 5,562 |
EBITDA | -573 | -103 | -1,027 | -1,493 |
EBIT | -778 | -312 | -1,245 | -1,589 |
Net Income | -777 | -206 | -1,166 | -1,561 |
Net Change In Cash | 10,402 | 10,194 | 9,635 | 8,838 |
Free Cash Flow | 12 | -489 | -680 | 983 |
Cash | 8,464 | 8,054 | 8,735 | 9,580 |
Basic Shares | 46,238 | 46,193 | 45,981 | 45,907 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $33,646 | $28,517 | $27,896 | $23,490 |
Gross Profit | 21,331 | 16,708 | 15,368 | 13,769 |
EBITDA | -5,673 | -9,399 | -10,193 | -6,566 |
EBIT | -6,446 | -10,269 | -10,780 | -7,029 |
Net Income | -6,066 | -13,741 | -8,661 | -4,562 |
Net Change In Cash | 33,646 | 28,517 | 27,896 | 23,490 |
Cost of Revenue | -7,926 | -1,980 | ||
Free Cash Flow | -1,617 | -5,707 | -8,206 | -4,694 |
Cash | 9,580 | 11,482 | 17,408 | 25,334 |
Basic Shares | 45,803 | 45,601 | 45,002 | 44,385 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.01 |
2025-06-30 | $0.01 |
2025-03-31 | -$0.03 |
